Ontvang nu dagelijks onze kooptips!

word abonnee
Van beleggers
voor beleggers
desktop iconMarkt Monitor

BioPharma« Terug naar discussie overzicht

INSM - Insmed - Deel 15

2.002 Posts
Pagina: «« 1 ... 34 35 36 37 38 ... 101 »» | Laatste | Omlaag ↓
  1. ludwig mack 28 juni 2007 22:16
    Last Trade: 0.8350
    Trade Time: 4:00PM ET
    Change: 0.0100 (1.21%)
    Prev Close: 0.825
    Open: 0.83
    Bid: 0.8350 x 8700
    Ask: 0.8400 x 7900
    1y Target Est: 2.00

    Day's Range: 0.8200 - 0.8500
    52wk Range: 0.68 - 1.98
    Volume: 1,647,641
    Avg Vol (3m): 1,916,780
    Market Cap: 84.61M
    P/E (ttm): N/A
    EPS (ttm): -0.526
    Div & Yield: N/A (N/A)

  2. ludwig mack 29 juni 2007 19:05
    Last Trade: 0.8386
    Trade Time: 12:49PM ET
    Change: 0.0036 (0.43%)
    Prev Close: 0.835
    Open: 0.8498
    Bid: 0.8386 x 4500
    Ask: 0.8387 x 2600
    1y Target Est: 2.00

    Day's Range: 0.8300 - 0.8500
    52wk Range: 0.68 - 1.98
    Volume: 567,358
    Avg Vol (3m): 1,937,560
    Market Cap: 84.97M
    P/E (ttm): N/A
    EPS (ttm): -0.526
    Div & Yield: N/A (N/A)


    houdt stand ...
  3. [verwijderd] 29 juni 2007 21:34
    quote:

    DoDD666 schreef:

    Er zit weer muziek in. Nu nog een paar posi trial berichten en we zijn weer boven jan.

    E.
    bodem is nu bevestigd
    toevoegen op zwakte nu geen slecht plan

    ik hoop nog steeds deze zomer op een ALS update

    dr allan zal ik op zijn vroegst ergens volgende week spreken
    heb het zelf alleen erg druk
  4. ludwig mack 29 juni 2007 22:27
    INSMED INC (NasdaqGM:INSM)

    After Hours: 0.80 0.01 (1.23%) as of 4:07PM ET on 06/29/07

    Last Trade: 0.8100
    Trade Time: 3:59PM ET
    Change: 0.0250 (2.99%)
    Prev Close: 0.84
    Open: 0.85
    Bid: 0.8000 x 100
    Ask: 0.8500 x 300
    1y Target Est: 2.00

    Day's Range: 0.7972 - 0.8500
    52wk Range: 0.68 - 1.98
    Volume: 1,221,194
    Avg Vol (3m): 1,960,670
    Market Cap: 82.07M
    P/E (ttm): N/A
    EPS (ttm): -0.53
    Div & Yield: N/A (N/A)


    erg vervelend, hij houdt niet stand, maar zal niet verder teruggaan dan waar hij eerder begin deze week was, denk ik.
    had ik ook niet hoeven bij te kopen ...........;(


  5. [verwijderd] 30 juni 2007 20:55
    quote:

    ludwig mack schreef:

    en wat verwacht je dan de volgende weken ? ook komkommertijd en weer dalen of toch wat stabiel rond deze koers ....
    gr
    zal nooit in 1 streep up gaan
    maar denk dat bodem op 0,70 er nu goed inzit
    zeker met insider buys

    hoop volgende week met dr allan te spreken, we shall see
  6. ludwig mack 2 juli 2007 16:19
    Last Trade: 0.81
    Trade Time: 10:00AM ET
    Change: 0.00 (0.62%)
    Prev Close: 0.81
    Open: 0.801
    Bid: 0.81 x 1800
    Ask: 0.82 x 1600
    1y Target Est: 2.00

    Day's Range: 0.80 - 0.82
    52wk Range: 0.68 - 1.98
    Volume: 88,005
    Avg Vol (3m): 1,931,340
    Market Cap: 82.58M
    P/E (ttm): N/A
    EPS (ttm): -0.526
    Div & Yield: N/A (N/A)

  7. ludwig mack 2 juli 2007 17:32
    Last Trade: 0.79
    Trade Time: 11:13AM ET
    Change: 0.02 (3.09%)
    Prev Close: 0.81
    Open: 0.801
    Bid: 0.79 x 100
    Ask: 0.79 x 2000
    1y Target Est: 2.00

    Day's Range: 0.78 - 0.82
    52wk Range: 0.68 - 1.98
    Volume: 279,500
    Avg Vol (3m): 1,931,340
    Market Cap: 79.54M
    P/E (ttm): N/A
    EPS (ttm): -0.526
    Div & Yield: N/A (N/A)


    jammer .......
  8. [verwijderd] 2 juli 2007 20:28
    Kennen we deze nog?
    Italiaans formulier van Agenzia Italiano del Farmacia van nov 2006?

    Owh buy you suck at bashing (5 Ratings) 2-Jul-07 11:09 am Too bad there is some information out there
    :p

    Insm cut back on non-essential spending, lowering their cash burn a lot. They got recent financing of nearly 20mln.
    Cash burn about 4mln per quarter....

    Now comes the fun part:

    Current italy expanded acces program : patient count 30+ ( 30-50 )

    Reimbursement is spoken about in italian official document 140.000euro, thats about 185.000$, say about 10% goes to cephalon.

    Let keep the small number of 30, thats about 5 million $ revenue for those few patients per year...
    And what does that make if the patient count is higher ?
    Say 40 or 50?

    here some automated translation for reference:
    "For the reasons over esposie one thinks that the reqmsiti minimums are not present in order to supply drug IGF-1 to patients affections from SLA. Moreover. the rile van revives to you necessary for qucsta therapy (approximately 140.000 euro for patient for year) must agree as embezzled to the treatments with scientific evidences proven for other paiologie. A conclusioae similar it regards also drug IGF-1/IGF-BP3 obviously: this drug and anch'esso auualmente indicated for the treatment over a long time span icnnine of the deficit of crcscita in children with primary deficiency of IGF-1 or GII (in this uliimo case, in the subjects that have developed antibodies anti-GH)
    "
    If your italian is good: happy reading, especially near the bottom on page 2.

    www.xs4all.nl/~surg3on/INSM/SLA-tratt...

  9. ludwig mack 2 juli 2007 22:25
    After Hours: 0.77 0.02 (2.53%) as of 4:01PM ET on 07/02/07

    Last Trade: 0.79
    Trade Time: 4:00PM ET
    Change: 0.02 (2.47%)
    Prev Close: 0.81
    Open: 0.80
    Bid: 0.78 x 900
    Ask: 0.79 x 1000
    1y Target Est: 2.00

    Day's Range: 0.78 - 0.82
    52wk Range: 0.68 - 1.98
    Volume: 625,693
    Avg Vol (3m): 1,977,560
    Market Cap: 80.05M
    P/E (ttm): N/A
    EPS (ttm): -0.53
    Div & Yield: N/A (N/A)


    nabeurs dus lager .......
2.002 Posts
Pagina: «« 1 ... 34 35 36 37 38 ... 101 »» | Laatste |Omhoog ↑